- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07046793
- Original Trial
Fracture Ultrasound in Kids Wirst Trial (FRUSKI-Wrist) (FRUSKI-Wrist)
July 21, 2025 updated by: David Troxler
This is a multicenter combined diagnostic accuracy study and observational prospective cohort.
Part one aims to confirm non-inferiority of POCUS for the detection of distal forearm fractures compared to X-ray.
Part two aims to confirm non-inforiority of POCUS compared to x-ray for the detection of potentially unstable forearm fractures needing follow up imaging.
Study Overview
Study Type
Observational
Enrollment (Actual)
815
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Lucerne, Switzerland
- Kinderspital zentralschweiz
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Children with wrist trauma
Description
Inclusion Criteria:
- Patients presenting to the emergency room of a study hospital with an acute trauma to the wrist and suspected fracture of the wrist consulted by a trained study examiner.
- Age 0-18 years Depending on the result
Exclusion Criteria:
- Patient needing immediate medical attention (triage score 1 or 2) as well as severely displaced or open fractures or neurovascular compromise distally to the suspected fracture.
- Patient with imaging studies obtained prior to the emergency room visit
- Patient with prior fracture of the affected wrist within the last 24 months
- Patient refusing participation / missing informed consent.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Fracture yes/no as final diagnosis
Time Frame: at 4 weeks from inclusion
|
at 4 weeks from inclusion
|
|
Possible unstable fracture as final diagnosis
Time Frame: 4 weeks from inclusion
|
4 weeks from inclusion
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2022
Primary Completion (Actual)
April 10, 2025
Study Completion (Actual)
April 10, 2025
Study Registration Dates
First Submitted
June 29, 2025
First Submitted That Met QC Criteria
June 29, 2025
First Posted (Actual)
July 2, 2025
Study Record Updates
Last Update Posted (Actual)
July 24, 2025
Last Update Submitted That Met QC Criteria
July 21, 2025
Last Verified
July 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2022-00376
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.